Weight Loss and Percutaneous Endoscopic Gastrostomy Tube Placement during Chemoradiotherapy for Locally Advanced Cancer of the Oropharynx Do Not Negatively Impact Outcomes
ObjectivesConcurrent chemoradiotherapy is standard of care in locally advanced oropharyngeal cancer (LA-OPC). This treatment regimen results in significant acute toxicities. This study investigates the effect of treatment-related toxicity on patient outcomes.MethodsPatient information was retrospect...
Main Authors: | Michael J. Baine, Timothy Dorius, Nathan Bennion, Lynette Smith, Weining Zhen, Apar Kishor Ganti |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fonc.2017.00299/full |
Similar Items
-
Concurrent chemoradiotherapy using cisplatin, tegafur, and leucovorin for advanced squamous cell carcinoma of the hypopharynx and oropharynx
by: Hung-Ming Wang, et al.
Published: (2014-06-01) -
Upfront <i>DPYD</i> Genotyping and Toxicity Associated with Fluoropyrimidine-Based Concurrent Chemoradiotherapy for Oropharyngeal Carcinomas: A Work in Progress
by: Antoine Desilets, et al.
Published: (2022-01-01) -
Predictors of Outcome after (Chemo)Radiotherapy for Node-Positive Oropharyngeal Cancer: The Role of Functional MRI
by: Pasqualina D’Urso, et al.
Published: (2022-05-01) -
Oropharynx Ulceration
by: Lauren Sylwanowicz, et al.
Published: (2017-09-01) -
Percutaneous Endoscopic Gastrostomy Tube Placement in Patients with Head and Neck Cancer Treated with Radiotherapy
by: Lang K, et al.
Published: (2020-01-01)